Vax Before Cancer

 / January 29th, 2023

Eliminating fake vaccine news with pharmacist, nurse, and physician review.

Jan 19 • 10:57 am CST
ImmunityBio, Inc. today announced positive results in its fully-enrolled metastatic pancreatic cancer study in third-line or greater subjects ( QUILT 88 ), showing that the overall survival (OS) rate for patients continues to be double compared...
Jan 18 • 4:16 pm CST
Evaxion Biotech A/S recently announced that the U.S. Food and Drug Administration (FDA) determined that the Company may proceed with its Phase 2b clinical trial of EVX-01 targeting malignant melanoma. The Phase 2b study will be...
Jan 12 • 2:16 pm CST
The American Cancer Society (ACS) today released Cancer Statistics, 2023, the organization's annual report on cancer facts and trends. According to the new ACS report , overall cancer mortality has dropped 33% since 1991, averting an...
Jan 12 • 8:50 am CST
Health Canada recently approved Enhertu™ for treating adult patients with unresectable or metastatic HER2-low (IHC 1+ or IHC 2+/ISH-) breast cancer who have received at least one prior line of chemotherapy in the metastatic setting or...
Nov 22 • 6:56 am CST
Northwest Biotherapeutics reported that in its Phase III clinical trial, median survival and the “long tail” of extended survival increased in newly diagnosed and recurrent glioblastoma brain cancer patients treated with DCVax®-L. The trial results published...

For more articles, try our search.